Authors: SETTE H PESSOA MG BARROS MA CURY RA MARUJO W TERRAULT NA

Citation: H. Sette et al., ASSESSING THE CONTRIBUTION OF TREATMENT DURATION TO RATE OF RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS-C (HCV) INFECTION RECEIVING COMBINED INTERFERON (IFN) AND RIBAVIRIN (RBV), Hepatology, 28(4), 1998, pp. 1650-1650

Authors: BARROS M SETTE H MARUJO W CURY R OSAWA C PEREIRA D VIANNA R

Citation: M. Barros et al., ACUTE URIC-ACID NEPHROPATHY ASSOCIATED TO RIBAVIRIN USE WHEN COMBINEDWITH CYCLOSPORINE AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 1400-1400

Authors: MARUJO W SETTE H BARROS M CURY R OSAWA C

Citation: W. Marujo et al., SEVERE ANEMIA INDUCED BY RIBAVIRIN USE WHEN COMBINED WITH CYCLOSPORINE IN LIVER-TRANSPLANT PATIENTS, Hepatology, 26(4), 1997, pp. 1717-1717

Authors: ZERBINI MC ALMEIDA W WAKAMATSU A MARUJO W LOPES LHAC MAKSOUD JG

Citation: Mc. Zerbini et al., DNA CONTENT AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN PERSISTENT NEONATAL HYPERINSULINEMIC HYPOGLYCEMIA (PNHH), Laboratory investigation, 70(1), 1994, pp. 10000149-10000149